ClinConnect ClinConnect Logo
Search / Trial NCT06066619

Can Cranberry Juice Enhance the Cognition Accuracy and Alleviate Negative Mental Consequences During Multitasking?

Launched by UNIVERSITY OF FLORIDA · Sep 27, 2023

Trial Information

Current as of August 02, 2025

Suspended

Keywords

ClinConnect Summary

This clinical trial is looking into whether drinking cranberry juice for 70 days can help improve how well people think and perform tasks, especially when they are juggling multiple things at once. The study focuses on healthy men and women aged 30 to 55 who experience stress from multitasking. Researchers believe that cranberry juice, which is rich in beneficial compounds, may help reduce mental stress, improve focus, and even enhance memory. The trial will involve participants consuming either cranberry juice or a placebo (a drink that looks like cranberry juice but has no active ingredients) without knowing which one they are drinking.

To participate, individuals must weigh at least 110 pounds, be between 30 and 55 years old, and have a body mass index (BMI) within a certain range. However, those with certain health issues, high caffeine or alcohol intake, or other specific conditions will not be eligible. Participants can expect to undergo assessments of their cognitive abilities and stress levels during the study, and they'll also need to follow some dietary guidelines. This research might provide valuable insights into how cranberry juice could help people manage stress and improve their thinking skills in daily life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Weight ≥110 pounds;
  • Age 30-55;
  • BMI 18.9-29.9 kg/m\^2;
  • Education level high school and above
  • Exclusion Criteria:
  • 1. Heavy caffeine user (\>300 mg caffeine/day or more than 2 cups of coffee/day);
  • 2. Alcohol consumption (\>3 alcohol/week);
  • 3. Smoking (≥10 years);
  • 4. Taking cannabis products;
  • 5. Uncontrolled hypertension;
  • 6. Clinically diagnosed illnesses, such as diabetes, cardiovascular disease, neurological disorders, and mental diseases;
  • 7. Taking medications (antibiotics, etc.) that may influence study outcomes;
  • 8. Taking vitamin/mineral supplements and are not willing to stop for the duration of the study;
  • 9. Have specific dietary restriction (prevent from consuming the standardized breakfast or dinner sandwiches);
  • 10. Inability to perform multitasking;
  • 11. Inability to do blood collection on arm;
  • 12. Inability to being video recorded while performing multitasking;
  • 13. Inability to comply with dietary restrictions for the entire duration of the study;
  • 14. Beck's depression inventory score of ≥21 during screening;
  • 15. Beck's anxiety inventory score ≥21 during screening;
  • 16. Severe suicidal tendencies (≥2);
  • 17. Having seasonal depression;
  • 18. Pregnancy;
  • 19. Breast-feeding;
  • 20. Female participants will do four pregnancy tests and their menstruation cycle need to be recorded. Female participants who do not wish to do pregnancy tests or record their menstruation cycle will be excluded.

About University Of Florida

The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.

Locations

Gainesville, Florida, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported